{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:01:23Z","timestamp":1791018083691,"version":"4.1.0"},"reference-count":65,"publisher":"Informa UK Limited","issue":"1","funder":[{"name":"San Pedro Guild","award":["K24CA8275401 and P30CA14089"],"award-info":[{"award-number":["K24CA8275401 and P30CA14089"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.2217\/pgs.10.163","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T11:01:21Z","timestamp":1293015681000},"page":"27-39","source":"Crossref","is-referenced-by-count":19,"title":["Gender-Specific Genomic Profiling in Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil and Oxaliplatin"],"prefix":"10.1080","volume":"12","author":[{"given":"Michael A","family":"Gordon","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, University of Southern California\/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, University of Southern California\/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, University of Southern California\/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syma","family":"Iqbal","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, University of Southern California\/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"El-Khouiery","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, University of Southern California\/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, University of Southern California\/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lurje","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, University of Southern California\/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Labonte","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Southern California\/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Southern California\/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Sherrod","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Southern California\/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D","family":"Ladner","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Southern California\/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Josef","family":"Lenz","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, University of Southern California\/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA90033, USA"},{"name":"Department of Preventive Medicine, University of Southern California\/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA90033, USA"},{"name":"Department of Pathology, University of Southern California\/Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA90033, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2010,12,22]]},"reference":[{"key":"e_1_3_4_3_1_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20006"},{"key":"e_1_3_4_3_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/07357900600896281"},{"key":"e_1_3_4_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2008.10.002"},{"key":"e_1_3_4_3_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500012"},{"key":"e_1_3_4_3_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601975"},{"issue":"6","key":"e_1_3_4_3_6_1","first-page":"237","article-title":"Predictive and prognostic markers in colorectal cancer.","volume":"1","author":"Wilson PM","year":"2007","unstructured":"Wilson PM , LadnerRD, LenzHJ: Predictive and prognostic markers in colorectal cancer.Gastrointest. Cancer Res.1(6) , 237\u2013246 (2007).","journal-title":"Gastrointest. Cancer Res."},{"key":"e_1_3_4_3_7_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.64.070195.003445"},{"issue":"2","key":"e_1_3_4_3_8_1","first-page":"645","article-title":"Prognostic and predictive value of thymidylate synthase expression in primary colorectal cancer.","volume":"30","author":"Karlberg M","year":"2010","unstructured":"Karlberg M , OhrlingK, EdlerD, HallstromM, UllenH, RagnhammarP: Prognostic and predictive value of thymidylate synthase expression in primary colorectal cancer.Anticancer Res.30(2) , 645\u2013651 (2010).","journal-title":"Anticancer Res."},{"issue":"1","key":"e_1_3_4_3_9_1","first-page":"56","article-title":"Methylenetetrahydrofolate reductase.","volume":"24","author":"Rosenblatt DS","year":"2001","unstructured":"Rosenblatt DS : Methylenetetrahydrofolate reductase.Clin. Invest. Med.24(1) , 56\u201359 (2001).","journal-title":"Clin. Invest. Med."},{"key":"e_1_3_4_3_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.4710"},{"key":"e_1_3_4_3_11_1","volume-title":"Antioxid. Redox Signal","author":"Earley JN","year":"2010","unstructured":"Earley JN , TurchiJ: Interrogation of nucleotide excision repair capacity: impact on platinum-based cancer therapy.Antioxid. Redox Signal (2010) (Epub ahead of print)."},{"issue":"7","key":"e_1_3_4_3_12_1","first-page":"2531","article-title":"Oxaliplatin resistance induced by ERCC1 up-regulation is abrogated by siRNA-mediated gene silencing in human colorectal cancer cells.","volume":"30","author":"Seetharam RN","year":"2010","unstructured":"Seetharam RN , SoodA, Basu-MallickA, AugenlichtLH, MariadasonJM, GoelS: Oxaliplatin resistance induced by ERCC1 up-regulation is abrogated by siRNA-mediated gene silencing in human colorectal cancer cells.Anticancer Res.30(7) , 2531\u20132538 (2010).","journal-title":"Anticancer Res."},{"key":"e_1_3_4_3_13_1","doi-asserted-by":"publisher","DOI":"10.2217\/14622416.8.12.1693"},{"key":"e_1_3_4_3_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e31817be58e"},{"key":"e_1_3_4_3_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0327"},{"key":"e_1_3_4_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)00772-2"},{"issue":"4","key":"e_1_3_4_3_17_1","first-page":"1213","article-title":"Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro.","volume":"150","author":"Laniado ME","year":"1997","unstructured":"Laniado ME , LalaniEN, FraserSPetal : Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro.Am. J. Pathol.150(4) , 1213\u20131221 (1997).","journal-title":"Am. J. Pathol."},{"key":"e_1_3_4_3_18_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.2001.85.5.2293"},{"key":"e_1_3_4_3_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0694"},{"key":"e_1_3_4_3_20_1","first-page":"724","article-title":"Genetic polymorphisms of GSTP1 related to response to 5-FU-oxaliplatin-based chemotherapy and clinical outcome in advanced colorectal cancer patients.","volume":"139","author":"Jun L","year":"2009","unstructured":"Jun L , HaipingZ, BeibeiY: Genetic polymorphisms of GSTP1 related to response to 5-FU-oxaliplatin-based chemotherapy and clinical outcome in advanced colorectal cancer patients.Swiss. Med. Wkly139(49\u201350) , 724\u2013728 (2009).","journal-title":"Swiss. Med. Wkly"},{"key":"e_1_3_4_3_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1930"},{"issue":"5","key":"e_1_3_4_3_22_1","first-page":"479","article-title":"Glutathione-S-transferase P1 expression and activity is increased in colonic neoplasia.","volume":"17","author":"Naidu KA","year":"2003","unstructured":"Naidu KA , NasirA, PinkasH, KaiserHE, BradyP, CoppolaD: Glutathione-S-transferase P1 expression and activity is increased in colonic neoplasia.In vivo17(5) , 479\u2013482 (2003).","journal-title":"In vivo"},{"key":"e_1_3_4_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90246-1"},{"key":"e_1_3_4_3_24_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4843"},{"key":"e_1_3_4_3_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2005.10.041"},{"key":"e_1_3_4_3_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208231200"},{"key":"e_1_3_4_3_27_1","volume-title":"Int. J. Cancer","author":"Ning Y","year":"2010","unstructured":"Ning Y , ManegoldPC, HongYKetal : Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models.Int. J. Cancer (2010) (Epub ahead of print)."},{"key":"e_1_3_4_3_28_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i37.4996"},{"key":"e_1_3_4_3_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/19.13.3159"},{"key":"e_1_3_4_3_30_1","doi-asserted-by":"publisher","DOI":"10.3816\/CCC.2007.n.011"},{"key":"e_1_3_4_3_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805019"},{"key":"e_1_3_4_3_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2008.07.017"},{"key":"e_1_3_4_3_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2809"},{"key":"e_1_3_4_3_34_1","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2010.51.5.692"},{"issue":"2","key":"e_1_3_4_3_35_1","first-page":"632","article-title":"Expression of estrogen receptor (ER) subtypes and ER\u03b2 isoforms in colon cancer.","volume":"61","author":"Campbell-Thompson M","year":"2001","unstructured":"Campbell-Thompson M , LynchIJ, BhardwajB: Expression of estrogen receptor (ER) subtypes and ER\u03b2 isoforms in colon cancer.Cancer Res.61(2) , 632\u2013640 (2001).","journal-title":"Cancer Res."},{"key":"e_1_3_4_3_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0511271103"},{"key":"e_1_3_4_3_37_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i2.214"},{"key":"e_1_3_4_3_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(03)00239-9"},{"key":"e_1_3_4_3_39_1","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.00861"},{"key":"e_1_3_4_3_40_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2718"},{"key":"e_1_3_4_3_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008469-199303000-00003"},{"key":"e_1_3_4_3_42_1","doi-asserted-by":"publisher","DOI":"10.1093\/pubmed\/fdn019"},{"key":"e_1_3_4_3_43_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.600.11.2"},{"key":"e_1_3_4_3_44_1","doi-asserted-by":"publisher","DOI":"10.1086\/516650"},{"key":"e_1_3_4_3_45_1","doi-asserted-by":"publisher","DOI":"10.1086\/378098"},{"key":"e_1_3_4_3_46_1","unstructured":"Breiman L FriedmanJH OlshenRA StoneCJ: Classification and Regression Trees . Chapman & Hall (Wadsworth Inc) NY USA (1984)."},{"key":"e_1_3_4_3_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.10.032"},{"key":"e_1_3_4_3_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2715"},{"key":"e_1_3_4_3_49_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0235"},{"key":"e_1_3_4_3_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgn189"},{"key":"e_1_3_4_3_51_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0407346102"},{"key":"e_1_3_4_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2008.07.011"},{"key":"e_1_3_4_3_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03437.x"},{"key":"e_1_3_4_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00667-1"},{"key":"e_1_3_4_3_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10265"},{"issue":"4","key":"e_1_3_4_3_56_1","first-page":"854","article-title":"Length and loss of heterozygosity of an intron 1 polymorphic sequence of EGFR is related to cytogenetic alterations and epithelial growth factor receptor expression.","volume":"60","author":"Buerger H","year":"2000","unstructured":"Buerger H , GebhardtF, SchmidtHetal : Length and loss of heterozygosity of an intron 1 polymorphic sequence of EGFR is related to cytogenetic alterations and epithelial growth factor receptor expression.Cancer Res.60(4) , 854\u2013857 (2000).","journal-title":"Cancer Res."},{"key":"e_1_3_4_3_57_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.19.13176"},{"key":"e_1_3_4_3_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930510304"},{"key":"e_1_3_4_3_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-007-0736-0"},{"key":"e_1_3_4_3_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/0888-7543(95)80093-2"},{"key":"e_1_3_4_3_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2005.10.010"},{"key":"e_1_3_4_3_62_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0514"},{"key":"e_1_3_4_3_63_1","volume-title":"Pharmacogenomics J.","author":"Press OA","year":"2010","unstructured":"Press OA , ZhangW, GordonMAetal : Gender-related survival differences associated with polymorphic variants of estrogen receptor-\u03b2 (ER\u03b2) in patients with metastatic colon cancer.Pharmacogenomics J. (2010) (Epub ahead of print)."},{"key":"e_1_3_4_3_64_1","doi-asserted-by":"publisher","DOI":"10.2131\/jts.33.237"},{"key":"e_1_3_4_4_2_1","unstructured":"Therneau TM Atkinson EJ: An introduction to recursive partitioning using the RPART routine. Technical Report 61 Mayo Clinic Section of Statistics (1997). www.mayo.edu\/hsr\/techrpt\/61.pdf"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs.10.163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T17:26:53Z","timestamp":1715966813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs.10.163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,22]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.2217\/pgs.10.163"],"URL":"https:\/\/doi.org\/10.2217\/pgs.10.163","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,22]]}}}